Literature DB >> 16464748

Rotenone produces opposite effects upon mouse striatal dopamine function as a result of environmental temperature.

Karla C Crutchfield1, Dean E Dluzen.   

Abstract

Rotenone is a commonly used pesticide that can function as an environmental neurotoxin. Rotenone is a known mitochondrial complex I inhibitor which can lead to oxidative stress and results in dopaminergic cell death. Another environmental factor known to exacerbate oxidative stress and result in striatal dopaminergic cell death is elevated environmental temperature. In this study we evaluated the effects of a single injection of various doses of rotenone (0.65, 1.3 and 2.6 mg/kg) on striatal dopamine (DA) and 3,4-dihydroxyphenylacetic acid (DOPAC) concentrations in CD-1 mice and compared this with a single injection of two doses of methamphetamine (MA - 10 or 20 mg/kg), a known striatal DA depleting agent, as administered to mice maintained at 21 degrees C (Experiment 1). These results were then compared to striatal DA and DOPAC concentrations of mice treated with rotenone (1.3 or 2.6 mg/kg) or MA (10 or 20 mg/kg) administered to mice maintained at 28 degrees C (Experiment 2). A single injection of rotenone to mice maintained at 21 degrees C resulted in a significant increase in DA and decrease in DOPAC concentrations for all doses tested compared to controls, whereas a single injection of MA at the same temperature resulted in a significant decrease in DA and no change in DOPAC concentrations. At a temperature of 28 degrees C, a single injection of rotenone resulted in a significant decrease in both DA and DOPAC concentrations similar to that seen with the MA-treated mice. Collectively, these results indicate that rotenone interacts with environmental temperature to produce opposite effects upon striatal DA concentrations -- significantly increasing striatal DA when administered at 21 degrees C and significantly decreasing striatal DA when administered at 28 degrees C, while producing similar decreases in striatal DOPAC under both temperatures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16464748     DOI: 10.1007/BF03033303

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  33 in total

Review 1.  Role of environmental stress in the physiological response to chemical toxicants.

Authors:  Christopher J Gordon
Journal:  Environ Res       Date:  2003-05       Impact factor: 6.498

2.  Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.

Authors:  Y Mizuno; S Ohta; M Tanaka; S Takamiya; K Suzuki; T Sato; H Oya; T Ozawa; Y Kagawa
Journal:  Biochem Biophys Res Commun       Date:  1989-09-29       Impact factor: 3.575

Review 3.  Mechanistic approaches to Parkinson's disease pathogenesis.

Authors:  Ranjita Betarbet; Todd B Sherer; Donato A Di Monte; J Timothy Greenamyre
Journal:  Brain Pathol       Date:  2002-10       Impact factor: 6.508

4.  Increased striatal dopamine turnover following acute administration of rotenone to mice.

Authors:  C Thiffault; J W Langston; D A Di Monte
Journal:  Brain Res       Date:  2000-12-08       Impact factor: 3.252

5.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease.

Authors:  R Betarbet; T B Sherer; G MacKenzie; M Garcia-Osuna; A V Panov; J T Greenamyre
Journal:  Nat Neurosci       Date:  2000-12       Impact factor: 24.884

6.  Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.

Authors:  L Y Moy; D S Albers; P K Sonsalla
Journal:  Brain Res       Date:  1998-04-20       Impact factor: 3.252

7.  Elevated environmental temperature and methamphetamine neurotoxicity.

Authors:  Diane B Miller; James P O'Callaghan
Journal:  Environ Res       Date:  2003-05       Impact factor: 6.498

Review 8.  Animal models of Parkinson's disease.

Authors:  Ranjita Betarbet; Todd B Sherer; J Timothy Greenamyre
Journal:  Bioessays       Date:  2002-04       Impact factor: 4.345

Review 9.  The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.

Authors:  S Fahn; G Cohen
Journal:  Ann Neurol       Date:  1992-12       Impact factor: 10.422

10.  Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain.

Authors:  Valentina Bashkatova; Mesbah Alam; Anatoly Vanin; Werner J Schmidt
Journal:  Exp Neurol       Date:  2004-04       Impact factor: 5.330

View more
  2 in total

1.  Benefits of betanin in rotenone-induced Parkinson mice.

Authors:  Wachiryah Thong-Asa; Sujira Jedsadavitayakol; Suchawalee Jutarattananon
Journal:  Metab Brain Dis       Date:  2021-08-26       Impact factor: 3.584

2.  Toxicokinetics and toxicodynamics of paraquat accumulation in mouse brain.

Authors:  Kavita Prasad; Elizabeth Tarasewicz; Jason Mathew; Pamela A Ohman Strickland; Brian Buckley; Jason R Richardson; Eric K Richfield
Journal:  Exp Neurol       Date:  2008-11-21       Impact factor: 5.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.